In updated guidelines for breast cancer, the National Comprehensive Cancer Network recognized the Oncotype DX Breast Recurrence Score test as the only test that can be used for prediction of chemotherapy benefit in early-stage breast cancer patients with one to three positive axillary lymph nodes, including micro metastases.
MD Anderson Cancer Center and TriSalus Life Sciences are collaborating to evaluate the treatment of tumors of the pancreas and liver by integrating interventional delivery of SD-101, an investigational toll-like receptor 9 (TLR9) agonist, in combination with checkpoint inhibition immunotherapy.
The likelihood that a patient walking through the doors of a radiation oncology clinic has advanced disease has increased since the start of the COVID-19 pandemic, a survey from the American Society for Radiation Oncology found.
In his upcoming budget proposal, President Joe Biden is expected to announce plans for a new, DARPA-like federal entity with a mission of accelerating cures for cancer and other diseases.
Lisa M. Coussens was elected president-elect of the American Association for Cancer Research for 2021-2022.She will officially become president-elect on April 12, 2021, during the AACR’s business meeting of members, and will assume the presidency in April 2022 at the next AACR annual meeting.
Matthew Vander Heiden, an MIT professor of biology was named the director of MIT’s Koch Institute for Integrative Cancer Research, effective April 1.Vander Heiden will succeed Tyler Jacks, who has served as director for more than 19 years, first for the MIT Center for Cancer Research and then for its successor, the Koch Institute.
Lucile Adams-Campbell received the Joseph F. Fraumeni, Jr., Distinguished Achievement Award, and Carolyn “Bo” Aldigé received the Joseph W. Cullen Memorial Award during the American Society of Preventive Oncology annual meeting March 29-April 1.
Narjust Duma was named associate director of the Cancer Care Equity Program at Dana-Farber Cancer Institute and Harvard Medical School, effective Aug. 2.
Neeraj Agarwal was named senior director of clinical research innovation at Huntsman Cancer Institute at the University of Utah.
FY21 Ovarian Cancer Research Program Program Announcements and General Application Instructions for the Omics Consortium Award are posted on the Grants.gov website.
